Cerebrolysin
Also known as: FPF 1070, Cerebrolysinum, Cerebrolysate
Cerebrolysin is a neuropeptide mixture derived from purified porcine (pig) brain proteins that mimics the actions of endogenous neurotrophic factors including BDNF, NGF, CNTF, and GDNF. It is approved in over 50 countries for stroke, traumatic brain injury, Alzheimer's disease, and cognitive decline. One of the most clinically studied neuropeptide preparations in existence. Available as lyophilized powder (60mg vials) for subcutaneous research use.
Regulatory & Approval Status
Cerebrolysin is approved for use in several international markets for neurological conditions but has not received FDA approval in the United States.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.